Imagion Biosystems is a biotech company aiming to make a difference to the lives of cancer patients, with groundbreaking imaging techniques being trialled in Australian hospitals.

CEO Bob Proulx joins Sean Aylmer from San Diego to talk about Imagion's work, and why they chose to list on the ASX.

Imagion Biosystems is a biotech company aiming to make a difference to the lives of cancer patients, with groundbreaking imaging techniques being trialled in Australian hospitals.
CEO Bob Proulx joins Sean Aylmer from San Diego to talk about Imagion's work, and why they chose to list on the ASX.

Business news you can use. A daily business news podcast with journalists Sean Aylmer and Michael Thompson. Find out more at https://fearandgreed.com.au

Business news you can use. A daily business news podcast with journalists <a href="https://www.linkedin.com/in/sean-aylmer-9922068/" data-saferedirecturl="https://www.google.com/url?q=https://www.linkedin.com/in/sean-aylmer-9922068/&amp;source=gmail&amp;ust=1689199223540000&amp;usg=AOvVaw0wu3ezGEfBZFYspJbTTaYL">Sean Aylmer</a>&nbsp;and&nbsp;<a href="https://www.linkedin.com/in/mcwthompson/" data-saferedirecturl="https://www.google.com/url?q=https://www.linkedin.com/in/mcwthompson/&amp;source=gmail&amp;ust=1689199223540000&amp;usg=AOvVaw08pZ8jZ88rHJgCfbHkTr5k">Michael Thompson</a>.&nbsp;Find out more at&nbsp;<a href="https://protect-au.mimecast.com/s/7AmQCOMxmAtl5q0qiE-KY7?domain=fearandgreed.com.au/" data-saferedirecturl="https://www.google.com/url?q=https://protect-au.mimecast.com/s/7AmQCOMxmAtl5q0qiE-KY7?domain%3Dfearandgreed.com.au/&amp;source=gmail&amp;ust=1689199223540000&amp;usg=AOvVaw1DLq_FuqjEt3HC-ZK1704H">https://fearandgreed.com.au</a>

Fear and Greed is Australia's most popular business podcast.

FEAR & GREED | Business News

Business journalist Sean Aylmer talks to leaders about all things business in the Fear and Greed daily interview. 

Business journalist <a href="https://www.linkedin.com/in/sean-aylmer-9922068/">Sean Aylmer</a> talks to leaders about all things business in the <a href="https://fearandgreed.com.au/">Fear and Greed</a> daily interview.

Business journalist Sean Aylmer talks to leaders about all things business in Fear and Greed Interviews.

Fear and Greed Interviews

Daily business news for people who make their own decisions, with business journalist Sean Aylmer and Michael Thompson. Find out more at https://fearandgreed.com.au

Daily business news for people who make their own decisions, with business journalist <a href="https://www.linkedin.com/in/sean-aylmer-9922068/">Sean Aylmer</a> and <a href="https://www.linkedin.com/in/mcwthompson/">Michael Thompson</a>. Find out more at <a href="https://protect-au.mimecast.com/s/7AmQCOMxmAtl5q0qiE-KY7?domain=fearandgreed.com.au/">https://fearandgreed.com.au</a>

Interview: Why this biotech chose the ASX over the NASDAQ

https://api.omny.fm/orgs/2fb3740d-3436-44af-8cc0-a91900716aa5/clips/2a586371-3c38-49c3-9053-af2300c1a9f6/transcript

Global markets have faced renewed volatility following the election of Donald Trump, but how much does it really matter for Australia? Sean Aylmer is joined by Westpac Chief Economist Luci Ellis to discuss the US, China and the forces shaping the global outlook in 2026. Luci also highlights a fast-growing but under-appreciated success story.

This episode is brought to you by Westpac. Fear & Greed's summer series - all-new short episodes every day, with regular news back from January 12.

Global markets have faced renewed volatility following the election of Donald Trump, but how much does it really matter for Australia? Sean Aylmer is joined by Westpac Chief Economist Luci Ellis to discuss the US, China and the forces shaping the global outlook in 2026. Luci also highlights a fast-growing but under-appreciated success story.
This episode is brought to you by Westpac. Fear &amp; Greed's summer series - all-new short episodes every day, with regular news back from January 12.

Our $9 billion export that nobody talks about

https://api.omny.fm/orgs/2fb3740d-3436-44af-8cc0-a91900716aa5/clips/c5bc7a7a-c157-4d86-b207-b3d200b96e60/transcript

Thursday 15 January 2026

Alphabet, the parent company of Google, hits a $US4 trillion valuation, making it the second largest stock on Wall Street. 
The federal opposition baulks at supporting Labor’s anti-vilification laws 
A record year for ETFs in Australia
House and unit rents are set to stabilise after years of growth
China’s trade surplus hits a record $US1.2 trillion, as Donald Trump’s tariffs re-order trade flows

Join our free daily newsletter here.

And don’t miss the latest episode of How Do They Afford That? - this week, your money bounceback plan. Get the episode from APPLE, SPOTIFY, or anywhere you listen to podcasts.

Thursday 15 January 2026
Alphabet, the parent company of Google, hits a $US4 trillion valuation, making it the second largest stock on Wall Street.&nbsp;
<ul>
<li aria-level="1">The federal opposition baulks at supporting Labor&rsquo;s anti-vilification laws&nbsp;</li>
<li aria-level="1">A record year for ETFs in Australia</li>
<li aria-level="1">House and unit rents are set to stabilise after years of growth</li>
<li aria-level="1">China&rsquo;s trade surplus hits a record $US1.2 trillion, as Donald Trump&rsquo;s tariffs re-order trade flows</li>
</ul>
Join our<a href="https://fearandgreed.com.au/newsletter-signup"> free daily newsletter here</a>.
And don&rsquo;t miss the latest episode of<a href="https://fearandgreed.com.au/how-do-they-afford-that-sugar-mamma-canna-campbell/"> How Do They Afford That?</a> - this week, your money bounceback plan. Get the episode from<a href="https://podcasts.apple.com/au/podcast/how-do-they-afford-that/id1644255235"> APPLE</a>,<a href="https://open.spotify.com/show/1EW5WRlRh7MovSBNkk6dG8?si=b2203ec2fa934a14"> SPOTIFY</a>, or anywhere you listen to podcasts.

Alphabet hits $US4 trillion; Coalition baulks at hate laws; record year for ETFs

https://api.omny.fm/orgs/2fb3740d-3436-44af-8cc0-a91900716aa5/clips/5f7ad8fe-8b1e-4e71-b0a1-b3d200b84c46/transcript

Wesfarmers is one of the most remarkable success stories on the ASX - a diversified conglomerate thriving in a world where many have failed. Sean Aylmer speaks with Gaurav Sodhi, Deputy Head of Research at Intelligent Investor, about what makes Wesfarmers different. From the extraordinary rise of Kmart’s Anko brand, to Bunnings’ near-monopoly power, and the company’s unique approach to capital allocation and management culture, Gaurav explains why Wesfarmers has delivered such strong long-term returns.

This is Fear & Greed's summer series - all-new short episodes every day, with regular news back from January 12. All information is general in nature. If you want to invest, we recommend you visit a financial advisor who can tailor investments to your needs

Wesfarmers is one of the most remarkable success stories on the ASX - a diversified conglomerate thriving in a world where many have failed. Sean Aylmer speaks with Gaurav Sodhi, Deputy Head of Research at Intelligent Investor, about what makes Wesfarmers different. From the extraordinary rise of Kmart&rsquo;s Anko brand, to Bunnings&rsquo; near-monopoly power, and the company&rsquo;s unique approach to capital allocation and management culture, Gaurav explains why Wesfarmers has delivered such strong long-term returns.
This is Fear &amp; Greed's summer series - all-new short episodes every day, with regular news back from January 12. All information is general in nature. If you want to invest, we recommend you visit a financial advisor who can tailor investments to your needs

Kmart's Anko and Bunnings: Wesfarmers' secret sauce

https://api.omny.fm/orgs/2fb3740d-3436-44af-8cc0-a91900716aa5/clips/049c35d3-8f74-49fc-8490-b3d100b46d2a/transcript

Interview: Why this biotech chose the ASX over the NASDAQ

In 1 playlist(s)

FEAR & GREED | Business News

Social links

Follow podcast

Recent clips